DBD
$63.20
▼ −0.46%09/18 O 63.50 H 64.89 L 62.14 C 63.20 ▼ −0.46%
Vol 602.4K RS 17
Vol 602.4K RS 17
RS rating17
Now vs pivot (%)−29.03%
Tightening (ATR ratio)1.18×
Volume dry-up1.05×
Up/down volume, net-0.09
From 52-week high31%
played out
Diebold Nixdorf, Incorporated
DBD · Calculating & Accounting Machines · $2.1B
Falling back
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year
The four are not in order. That is a description of where the averages sit, not a view about what happens next.
The read
The base has run 12.6 weeks and fell 24% from its ceiling at its deepest. The pivot is $89.05, and the stock closed 29.0% below it. Its relative strength rating is 17.
Peers
Catalyst roadmap
- Earningstentativein 47dQuarterly earningsNov 4, 2026
Flagged by the market sweep
Nothing flagged for this company on the last market sweep.
In the news
Wall Street Analysts See Diebold Nixdorf, Incorporated (DBD) as a Buy: Should You Invest?Zacks Investment Research · 2026-09-01
Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.
Insiders
No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.
X-ray